Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Submitted by
admin
on September 9, 2015 - 10:02pm
Source:
Bizjournals.com
News Tags:
Akebia Therapeutics
anemia
vadadustat
kidney disease
Headline:
Here’s the deal with Akebia’s anemia drug that caused a 50% stock hike today
Do Not Allow Advertisers to Use My Personal information